# Reproductive Medicine & Infertility Associates – FDA 483, Jul 31, 2026

Source: https://www.keypedia.com/records/483/reproductive-medicine-infertility-associates/d716d05d-a45e-4cfa-ae4e-a25cd6baf45e

> FDA 483 for Reproductive Medicine & Infertility Associates on July 31, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Reproductive Medicine & Infertility Associates
- Inspection Date: 2026-07-31
- Product Type: biologics
- Office Name: Atlanta District Office
- Summary: Reproductive Medicine & Infertility Associates in Augusta, GA, received a Form 483 for deficiencies in donor screening and testing procedures. The firm failed to adequately screen donors for communicable disease agents, including missing required physical examinations and medical history. Additionally, the company's standard operating procedures for HCT/P donor testing did not reference all required FDA tests.

## Related Officers

- [Nisha C. Patel](https://www.keypedia.com/people/nisha-c-patel/1b38764f-c7bc-4f90-9af1-54989ad6d59c)
- [Steven D. Banks](https://www.keypedia.com/people/steven-d-banks/30e4d016-e386-423d-9df8-1536cf43a0a3)

Company: https://www.keypedia.com/companies/reproductive-medicine-infertility-associates/e4d5d7f6-8d97-4c8e-98cf-10848b0fb790

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7